Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common Cold
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Editorials15 August 2000Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common ColdNorman A. Desbiens, MDNorman A. Desbiens, MDUniversity of Tennessee College of Medicine—Chattanooga Unit; Chattanooga, TN 37403 (Desbiens)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-4-200008150-00016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail “ … anything tasting as bad as zinc and with as much aftertaste as zinc must be good medicine” (1).Where would the evidentiary basis of medicine be without the randomized, double-blind, placebo-controlled trial? Over the past half-century, this type of trial has evolved from being considered an interesting statistical approach to being recognized as the study design associated with the least threat to the validity of findings (2). If only this trial could be applied to the study of every test, treatment, and diagnostic approach in clinical practice! However, with increased application has come greater awareness of its limitations ...References1. Farr BM, Gwaltney JM. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold. J Chronic Dis. 1987;40:875-9. CrossrefMedlineGoogle Scholar2. Shapiro AK, Shapiro E. The Powerful Placebo. Baltimore: Johns Hopkins Univ Pr; 1997:137-74. Google Scholar3. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet. 1998;351:1722-5. CrossrefMedlineGoogle Scholar4. Kienle GS, Kiene H. Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. Altern Ther Health Med. 1996;2:39-54. MedlineGoogle Scholar5. Ney PG, Collins C, Spensor C. Double blind: double talk or are there ways to do better research. Med Hypotheses. 1986;21:119-26. CrossrefMedlineGoogle Scholar6. Prasad AS, Fitzgerald JT, Bao B, Beck FW, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;133:245-52. LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: University of Tennessee College of Medicine—Chattanooga Unit; Chattanooga, TN 37403 (Desbiens)Corresponding Author: Norman A. Desbiens, MD, University of Tennessee College of Medicine—Chattanooga Unit, 975 East Third Street, Box 94, Chattanooga, TN 37403. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDuration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate Ananda S. Prasad , James T. Fitzgerald , Bin Bao , Frances W.J. Beck , and Pranatharthi H. Chandrasekar Blinding in Placebo-Controlled Trials Ananda S. Prasad Blinding in Placebo-Controlled Trials George E. Ehrlich Blinding in Placebo-Controlled Trials Norman A. Desbiens Metrics Cited ByReporting of placebo medication descriptors in randomised controlled trials: A review of three medical journalsMisrepresentation and distortion of research in biomedical literatureTemporal trends in dietary supplement prescriptions of United States military service members suggest a decrease in pyridoxine and increase in vitamin D supplements from 2005 to 2013The risk of unblinding was infrequently and incompletely reported in 300 randomized clinical trial publicationsBlinding in Randomized Clinical Trials: Imposed ImpartialityZinc lozenges for the common cold: Should we ignore the side-effects?BlindnessTowards a proposal for assessment of blinding success in clinical trials: up-to-date reviewTHE COMMON COLDCurrent and future therapeutic approaches to the common coldIn randomized controlled trials, should subjects in both placebo and drug groups be expected to guess that they are taking drug 50% of the time?The placebo effect and randomized trials: analysis of alternative medicineExperiencia, ciencia y “medicina basada en pruebas” en Atención PimariaBlinding in Placebo-Controlled TrialsAnanda S. Prasad, MD, PhDBlinding in Placebo-Controlled TrialsGeorge E. Ehrlich, MD 15 August 2000Volume 133, Issue 4Page: 302-303KeywordsAdverse reactionsClinical trialsCommon coldCytokinesDrug administrationDrugsOilsTasteZinc ePublished: 15 August 2000 Issue Published: 15 August 2000 CopyrightCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, some studies report “double-blind” methods, but the blinding is not credible (11, 12), or report an intent-to-treat analysis, but some patients are excluded from the analysis (13, 14).”
From Misrepresentation and distortion of research in biomedical literature (2018) · cites this paper as [11]
Citations
Cites
‘Powerful Placebo: The Dark Side of the Randomised Controlled Trial’
Kaptchuk, T. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10111-8 · Cited by 339
Prasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00006 · Cited by 228 · cited 3×
“Finally, continued investigation of the molecular mechanism of zinc, a feature of the study by Prasad and colleagues (6), would help us understand the molecular basis of its effectiveness.”
BackgroundInfluentialGs, K., & Kiene, H. (1996) · PubMed · Cited by 117
The problems of taste in placebo matching: An evaluation of zinc gluconate for the common cold
Farr, B. M., & Gwaltney, J. M. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90187-1 · Cited by 56 · cited 1×
“aftertaste as zinc must be good medicine” (1).”
BackgroundDouble blind: Double talk or are there ways to do better research
Ney, P. G., Collins, C. M., & Spensor, C. (1986) · Medical Hypotheses · doi:10.1016/0306-9877(86)90001-0 · Cited by 52
Research works printed but not linked: 1
- Kienle GS, 1996, Altern Ther Health Med, 2, 39
Cited by
Misrepresentation and distortion of research in biomedical literature
Boutron, I., & Ravaud, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710755115 · Cited by 273
Boutron, I., Estellat, C., Guittet, L., Dechartres, A., Sackett, D. L., Hróbjartsson, A., & Ravaud, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030425 · Cited by 166
“For example, unblinding may occur during the trial for patients and health care providers because of specific side effects or specific requirements such as dosage modification [10,11].”
BackgroundTowards a proposal for assessment of blinding success in clinical trials: up-to-date review
Kolahi, J., Bang, H., & Park, J. (2009) · Community Dentistry and Oral Epidemiology · doi:10.1111/j.1600-0528.2009.00494.x · Cited by 137
Blinding in Randomized Clinical Trials: Imposed Impartiality
Hróbjartsson, A., & Boutron, I. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.207 · Cited by 95
A review of blinding in randomized controlled trials found results inconsistent and questionable
Boutron, I., Estellat, C., & Ravaud, P. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.04.006 · Cited by 101
“For example, when assessing zinc treatment for the common cold, the blinding procedure could fail because the taste and aftertaste of zinc are distinctive [6,7].”
Background
Metadata
- Authors
- Desbiens, N. A.
- Affiliations
- University of Tennessee at Chattanooga (US)
- Corresponding author
- Desbiens, Norman A.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-08-15
- Volume
- 133
- Issue
- 4
- Pages
- 302-303
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1989685039
- Cited by
- 23
- References
- 5
- Citations by year
- 2025: 1 · 2020: 1 · 2018: 1 · 2016: 1 · 2014: 1
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Keywords
- zinc gluconate, common cold, placebo effect, blinding
- MeSH terms
- Common Cold, Double-Blind Method, Humans, Placebos, Research Design, Randomized Controlled Trials as Topic, Zinc Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common Cold. https://app.cochat.ai/papers/10.7326/0003-4819-133-4-200008150-00016
- The paper
- Desbiens, N. A. (2000). Lessons Learned from Attempts To Establish the Blind in Placebo-Controlled Trials of Zinc for the Common Cold. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-4-200008150-00016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.